|
(Title of Class of Securities)
70469L100
|
|
(CUSIP Number)
Frank S. Vellucci, Esq.
Norton Rose Fulbright US LLP
1301 Avenue of the AmericasNew York, NY 10019 (212) 408-5100 |
||
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
July 18, 2017 |
||
(Date of Event which Requires Filing of this Statement)
|
||
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subect of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.
|
CUSIP No. 70469L100
|
13D/A
|
Page 2 of 9 Pages |
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
|
|
|
|||
Cap 1 LLC
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
|
☐
|
||
(b)
|
☐
|
||||
|
|
||||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
|
|
|
||
PF
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
|
|
☐
|
||
|
|
||||
|
|
||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Delaware
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
|
|
|
|
7,696,373* shares of Common Stock
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER
|
|
|
||
7,696,373* shares of Common Stock
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
7,696,373* shares of Common Stock
|
|
|
|||
|
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
☐
|
||
|
|
||||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
||
38.7%1
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
OO
|
|
|
|||
|
|
* |
Consists of 1,797,705 shares of Common Stock, 3,179,650 shares of Common Stock issuable upon conversion of Series A Cumulative Convertible Preferred Stock issued on November 2, 2016, and an aggregate of 2,719,018 shares of Common Stock issuable upon exercise of warrants issued on November 2, 2016. Amendment No. 1 to the Schedule 13D filed with the Securities and Exchange Commission (the "SEC") on November 14, 2016 showed 1,218,613 shares of Common Stock instead of 1,263,613 due to a clerical error.
|
1 |
This calculation is rounded to the nearest tenth and is based upon 13,982,400 shares of common stock outstanding as of July 13, 2017 as reported in the Company's Annual Report on Form 10-K filed the SEC on July 13, 2017 and an aggregate of 5,898,668 shares of Common Stock issuable upon conversion of Series A Cumulative Convertible Preferred Stock and upon exercise of warrants.
|
CUSIP No. 70469L100
|
13D/A
|
Page 3 of 9 Pages |
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
|
|
|
|||
Richard S. Sackler, M.D.
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
|
☐
|
||
(b)
|
☐
|
||||
|
|
||||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
|
|
|
||
PF
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
|
|
☐
|
||
|
|
||||
|
|
||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
United States of America
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
|
|
|
|
102,595 shares of Common stock
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER
|
|
|
||
102,595 shares of Common Stock
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
102,595 shares of Common Stock
|
|
|
|||
|
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
☐
|
||
|
|
||||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
||
0.2%2
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
IN
|
|
|
|||
|
|
2 |
This calculation is rounded to the nearest tenth and is based upon 13,982,400 shares of common stock outstanding as of July 13, 2017 as reported in the Company's Annual Report on Form 10-K filed the SEC on July 13, 2017.
|
CUSIP No. 70469L100
|
13D/A
|
Page 4 of 9 Pages |
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
|
|
|
|||
Richard and Beth Sackler Foundation, Inc.
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
|
☐
|
||
(b)
|
☐
|
||||
|
|
||||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
|
|
|
||
PF
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
|
|
☐
|
||
|
|
||||
|
|
||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Delaware
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
|
|
|
|
26,200 shares of Common Stock
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER
|
|
|
||
26,200 shares of Common Stock
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
26,200 shares of Common Stock
|
|
|
|||
|
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
☐
|
||
|
|
||||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
||
0.2%3
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
CO
|
|
|
|||
|
|
3 |
This calculation is rounded to the nearest tenth and is based upon 13,982,400 shares of common stock outstanding as of July 13, 2017 as reported in the Company's Annual Report on Form 10-K filed the SEC on July 13, 2017.
|
CUSIP No. 70469L100
|
13D/A
|
Page 5 of 9 Pages |
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
|
|
|
|||
David Sackler
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
|
☐
|
||
(b)
|
☐
|
||||
|
|
||||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
|
|
|
||
PF
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
|
|
☐
|
||
|
|
||||
|
|
||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
United States of America
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
|
|
|
|
100,000 shares of Common Stock
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER
|
|
|
||
100,000 shares of Common Stock
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
100,000 shares of Common Stock
|
|
|
|||
|
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
☐
|
||
|
|
||||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
||
0.7%4
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
IN
|
|
|
|||
|
|
4 |
This calculation is rounded to the nearest tenth and is based upon 13,982,400 shares of common stock outstanding as of July 13, 2017 as reported in the Company's Annual Report on Form 10-K filed the SEC on July 13, 2017.
|
Item 2. |
Identity and Background.
|
Item 3. |
Source and Amount of Funds or Other Consideration.
|
Item 5. |
Interest in Securities of the Issuer.
|
Shares Beneficially Owned
|
Percent of Class5
|
|
1. Cap 16
|
||
Sole Voting Power
|
7,696,373
|
38.7%
|
Shared Voting Power
|
-0-
|
0%
|
Sole Dispositive Power
|
7,696,373
|
38.7%
|
Shared Dispositive Power
|
-0-
|
0%
|
Aggregate Voting and Dispositive Power
|
7,696,373
|
38.7%
|
2. Dr. Sackler
|
||
Sole Voting Power
|
102,595
|
0.7%
|
Shared Voting Power
|
-0-
|
0%
|
Sole Dispositive Power
|
102,595
|
0.7%
|
Shared Dispositive Power
|
-0-
|
0%
|
Aggregate Voting and Dispositive Power
|
102,595
|
0.7%
|
3. The Foundation
|
||
Sole Voting Power
|
26,200
|
0.2%
|
Shared Voting Power
|
-0-
|
0%
|
Sole Dispositive Power
|
26,200
|
0.2%
|
Shared Dispositive Power
|
-0-
|
0%
|
Aggregate Voting and Dispositive Power
|
26,200
|
0.2%
|
4. David Sackler
|
||
Sole Voting Power
|
100,000
|
0.7%
|
Shared Voting Power
|
-0-
|
0%
|
Sole Dispositive Power
|
100,000
|
0.7%
|
Shared Dispositive Power
|
-0-
|
0%
|
Aggregate Voting and Dispositive Power
|
100,000
|
0.7%
|
5 |
This calculation is rounded to the nearest tenth and is based upon 13,982,400 shares of common stock outstanding as of July 13, 2017 as reported in the Company's Annual Report on Form 10-K filed the SEC on July 13, 2017 and, in the case of the calculation for Cap 1 only, also includes an aggregate of 5,898,668 shares of Common Stock issuable upon conversion of the Preferred Stock and upon exercise of the Warrants.
|
6 |
Cap 1 LLC is a Delaware limited liability company wholly owned by Richard S. Sackler, M.D. and Jonathan D. Sackler, as Trustees of the 1974 Irrevocable Trust A FBO BS and RSS. The beneficiaries of the 1974 Irrevocable Trust A FBO BS and RSS are Beverly Sackler, Richard S. Sackler, M.D. and the issue of Richard S. Sackler, M.D. Its shares listed as beneficially owned in this table consist of 1,797,705 shares of Common Stock, 3,179,650 shares of Common Stock issuable upon conversion of the Preferred Stock and an aggregate of 2,719,018 shares of Common Stock issuable upon exercise of the Warrants. Amendment No. 1 showed 1,218,613 shares of Common Stock instead of 1,263,613 due to a clerical error. David Sackler is the president of Summer Road LLC and one of the beneficiaries of Cap 1 LLC. Cap 1 LLC is a family client of Summer Road LLC.
|
(c)
|
The following tables set forth all transactions in the shares of Common Stock effected by the Reporting Persons in the past sixty days. All such transactions were effected in the open market through various brokerage entities. The Reporting Persons undertake to provide upon request by the SEC staff full information regarding the number of shares of Common Stock purchased or sold at each separate price.
|
Trade Date
|
Shares Purchased
|
Weighted Average Price Per Share
|
Range of Prices
|
July 18, 2017
|
152,400
|
$4.82
|
$4.55 – $5.00
|
July 19, 2017
|
165,000
|
$5.35
|
$4.65 – $5.50
|
July 20, 2017
|
75,000
|
$5.47
|
$5.35 – $5.50
|
July 21, 2017
|
69,512
|
$5.55
|
$5.40 – $5.60
|
July 24, 2017
|
17,180
|
$5.58
|
$5.50 – $5.60
|
July 25, 2017
|
55,000
|
$5.56
|
$5.30 – $5.60
|
Trade Date
|
Shares Purchased
|
Weighted Average Price Per Share
|
Range of Prices
|
July 18, 2017
|
39,900
|
$4.96
|
$4.60 – $5.10
|
July 19, 2017
|
60,100
|
$5.34
|
$4.95 – $5.50
|
Item 7. |
Material to be Filed as Exhibits.
|
Exhibit A. |
Joint Filing Agreement, dated as of July 31, 2017, by and among Cap 1 LLC, Richard S. Sackler, M.D., Richard and Beth Sackler Foundation, Inc. and David Sackler.
|
Exhibit B. |
Power of Attorney, dated as of July 31, 2017, granted by David Sackler in favor of Stephen A. Ives.
|
Cap 1 LLC
|
|
By: /s/ Stephen A. Ives
|
|
Name: Stephen A. Ives
Title: Vice President |
|
Richard S. Sackler, M.D.
|
|
By: /s/ Stephen A. Ives
|
|
Name: Stephen A. Ives
Attorney-in-Fact for Richard S. Sackler, M.D. |
|
Richard and Beth Sackler Foundation, Inc.
|
|
By: /s/ Stephen A. Ives
|
|
Name: Stephen A. Ives
Attorney-in-Fact for Richard and Beth Sackler Foundation, Inc. |
David Sackler
|
|
By: /s/ Stephen A. Ives
|
|
Name: Stephen A. Ives
Attorney-in-Fact for David Sackler |
Cap 1 LLC
|
|
By: /s/ Stephen A. Ives
|
|
Name: Stephen A. Ives
Title: Vice President |
|
Richard S. Sackler, M.D.
|
|
By: /s/ Stephen A. Ives
|
|
Name: Stephen A. Ives
Attorney-in-Fact for Richard S. Sackler, M.D. |
|
Richard and Beth Sackler Foundation, Inc.
|
|
By: /s/ Stephen A. Ives
|
|
Name: Stephen A. Ives
Attorney-in-Fact for Richard and Beth Sackler Foundation, Inc. |
David Sackler
|
|
By: /s/ Stephen A. Ives
|
|
Name: Stephen A. Ives
Attorney-in-Fact for David Sackler |
/s/ David Sackler
|
|
David Sackler
|